These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9884282)

  • 21. Value of C3d assay and IgG subclass in the prediction of the flow cytometry cross-match result for renal transplantation.
    Contreras AG; Casillas-Abundis A; Alberú J; Llorente L; Lima G; Arvizu A; de Santiago A; Vilatobá M; Granados J; Morales-Buenrostro LE; Cruz R; Arreola-Guerra JM
    Transpl Immunol; 2018 Oct; 50():8-14. PubMed ID: 29885443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful kidney transplantation across a positive complement-dependent cytotoxicity crossmatch by using C1q assay-directed, bortezomib-assisted desensitization: A case report.
    Lee J; Park BG; Jeong HS; Park YH; Kim S; Kim BS; Kim HJ; Huh KH; Jeong HJ; Kim YS
    Medicine (Baltimore); 2017 Sep; 96(39):e8145. PubMed ID: 28953652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of donor-specific HLA antibodies: A retrospective observation in 350 renal transplant cases.
    Pandey P; Pande A; Mandal S; Marik A; Devra AK; Sinha VK; Bhatt AP; Gajway SY; Singh RK; Mishra S; Jha S
    Transpl Immunol; 2023 Apr; 77():101783. PubMed ID: 36608831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of HLA-specific antibodies by PRA-STAT and their association with transplant outcome.
    Worthington JE; Thomas AA; Dyer PA; Martin S
    Transplantation; 1998 Jan; 65(1):121-5. PubMed ID: 9448156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
    Kerman RH; Susskind B; Kerman D; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz S; Van Buren CT; Frazier H; Radovancevic B; Fife S; Kahan B
    J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of enzyme-linked immunosorbent assay-detected IgG anti-HLA antibodies for pediatric renal allograft rejection.
    Dalla Vecchia LK; Book BK; Milgrom ML; Jindal RM; Leapman SB; Filo RS; Pescovitz MD
    Transplantation; 1997 Dec; 64(12):1744-7. PubMed ID: 9422414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of HLA IgG antibodies by two enzyme-linked immunoassays, solubilized HLA class I and PRA-STAT. Comparison with the AHG PRA.
    Bryan CF; Baier KA; Flora-Ginter G; Shield CF; Warady BA; Aeder MI; Borkon AM; Estep TH; Forster J; Landreneau MD
    Transplantation; 1995 Dec; 60(12):1588-94. PubMed ID: 8545895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superiority of AbCross enzyme-linked immunosorbent assay cross-match over the B-cell complement-dependent lymphocytotoxicity cross-match.
    Gombos P; Opelz G; Scherer S; Morath C; Zeier M; Schemmer P; Langer RM; Süsal C
    Transplant Proc; 2013 May; 45(4):1383-5. PubMed ID: 23726578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation analysis between virtual and Complement-Dependent-Cytotoxicity crossmatch in a monocenter retrospective series of 118 allografted patients.
    Crocchiolo R; Lo Po' S; Lumia D; Lando G; Cornacchini G; Crucitti L; Pugliano MT; Volpato E; Cuppari I; Sommaruga E; Pipitone MG; Labate S; Grillo G; Zucchetti E; Rossini S
    Curr Res Transl Med; 2021 May; 69(2):103287. PubMed ID: 33765638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
    Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
    Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poor kidney allograft survival associated with positive B cell - Only flow cytometry cross matches: a ten year single center study.
    Norin AJ; Mondragon-Escorpizo MO; Brar A; Hochman D; Sumrani N; Distant DA; Salifu MO
    Hum Immunol; 2013 Oct; 74(10):1304-12. PubMed ID: 23811689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody monitoring system to support the single-antigen Luminex assay in donor-specific antibody detection.
    Hwang HS; Sun IO; Yoon HE; Choi BS; Oh EJ; Kim JI; Moon IS; Kim YS; Yang CW
    Hum Immunol; 2012 Apr; 73(4):370-5. PubMed ID: 22342452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-reactivity between swine leukocyte antigen and human anti-HLA-specific antibodies in sensitized patients awaiting renal transplantation.
    Díaz Varela I; Sánchez Mozo P; Centeno Cortés A; Alonso Blanco C; Valdés Cañedo F
    J Am Soc Nephrol; 2003 Oct; 14(10):2677-83. PubMed ID: 14514748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance.
    Schönemann C; Groth J; Leverenz S; May G
    Transplantation; 1998 Jun; 65(11):1519-23. PubMed ID: 9645818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
    Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
    Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extra reactivities detected in flow-cytometry-positive, CDC-negative crossmatches are definable HLA specificities.
    Rodey G; Bollig B; Oldfather J; Schutte L; Flye W; Phelan D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):778-9. PubMed ID: 3274872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New crossmatch technique eliminates interference by humanized and chimeric monoclonal antibodies.
    Book BK; Agarwal A; Milgrom AB; Bearden CM; Sidner RA; Higgins NG; Pescovitz MD
    Transplant Proc; 2005 Mar; 37(2):640-2. PubMed ID: 15848485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxic Antibody Detection by Means of Flow-Cytometric Cross-Match.
    Bilgen T; Ata P; Tozkir J; Tozkir H; Titiz MI
    Transplant Proc; 2017 Apr; 49(3):440-444. PubMed ID: 28340808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies.
    Amico P; Hönger G; Bielmann D; Lutz D; Garzoni D; Steiger J; Mihatsch MJ; Dragun D; Schaub S
    Transplantation; 2008 Jun; 85(11):1557-63. PubMed ID: 18551059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
    Bućin D; Johansson S; Lindberg LO
    Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.